ZA200403614B - Controlled release tablets of metformin. - Google Patents

Controlled release tablets of metformin.

Info

Publication number: ZA200403614B
Authority: ZA; South Africa
Prior art keywords: metformin; controlled release; release tablets; tablets; controlled
Prior art date: 2001-11-06

Application number

ZA200403614A

Other languages

English (en)

Inventor

Manish Chawla

Rajeev S Raghuvanshi

Ashok Rampal

Original Assignee

Ranbaxy Lab Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-06

Filing date

2004-05-12

Publication date

2005-01-14

2004-05-12 Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd

2005-01-14 Publication of ZA200403614B publication Critical patent/ZA200403614B/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA200403614A 2001-11-06 2004-05-12 Controlled release tablets of metformin. ZA200403614B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IN1134DE2001		2001-11-06

Publications (1)

Publication Number	Publication Date
ZA200403614B true ZA200403614B (en)	2005-01-14

Family

ID=11097132

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200403614A ZA200403614B (en)	2001-11-06	2004-05-12	Controlled release tablets of metformin.

Country Status (9)

Country	Link
US (1)	US20030104059A1 (xx)
EP (1)	EP1465612A1 (xx)
KR (1)	KR20050043765A (xx)
CN (1)	CN1700910A (xx)
EA (1)	EA200400628A1 (xx)
HU (1)	HUP0402058A3 (xx)
PL (1)	PL369328A1 (xx)
WO (1)	WO2003039527A1 (xx)
ZA (1)	ZA200403614B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1515701B1 (en) *	2002-06-17	2014-09-17	Inventia Healthcare Private Limited	Process for the manufacture of multilayer tablet compositions comprising thiazolidinedione and biguanide
CN1805738A (zh) *	2003-06-16	2006-07-19	兰贝克赛实验室有限公司	持续释放的二甲双胍片剂
WO2005092293A1 (en) *	2004-03-22	2005-10-06	Ranbaxy Laboratories Limited	Formulations of metformin
EP1814528A2 (en) *	2004-10-08	2007-08-08	Rubicon Research Private Limited	Process for making a highly compressible controlled delivery compositions of metformin
BR112012011274A2 (pt) *	2009-11-13	2016-04-12	Astrazeneca Uk Ltd	formulação de metformina de massa reduzida e sua combinação
US9572784B2 (en)	2011-01-07	2017-02-21	Elcelyx Therapeutics, Inc.	Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
US8796338B2 (en)	2011-01-07	2014-08-05	Elcelyx Therapeutics, Inc	Biguanide compositions and methods of treating metabolic disorders
US11974971B2 (en)	2011-01-07	2024-05-07	Anji Pharmaceuticals Inc.	Compositions and methods for treating metabolic disorders
US9480663B2 (en)	2011-01-07	2016-11-01	Elcelyx Therapeutics, Inc.	Biguanide compositions and methods of treating metabolic disorders
LT2661266T (lt)	2011-01-07	2020-12-10	Anji Pharma (Us) Llc	Gydimo būdai chemosensorinio receptoriaus ligando pagrindu
US9211263B2 (en)	2012-01-06	2015-12-15	Elcelyx Therapeutics, Inc.	Compositions and methods of treating metabolic disorders
US11759441B2 (en)	2011-01-07	2023-09-19	Anji Pharmaceuticals Inc.	Biguanide compositions and methods of treating metabolic disorders
KR20230095124A (ko)	2012-01-06	2023-06-28	앤지 파마 유에스 엘엘씨	바이구아나이드 조성물 및 대사 장애를 치료하는 방법
CN104349773A (zh)	2012-01-06	2015-02-11	埃尔舍利克斯治疗公司	用于治疗代谢性病症的组合物和方法
WO2016042567A1 (en) *	2014-09-16	2016-03-24	Suresh Pareek	Extended release formulation of metformin
KR102856843B1 (ko) *	2020-03-30	2025-09-08	한미약품 주식회사	시타글립틴, 다파글리플로진, 및 메트포르민을 포함하는 경구용 복합정제

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4432757A1 (de) *	1994-09-14	1996-03-21	Boehringer Mannheim Gmbh	Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung
PT998271E (pt) *	1997-06-06	2005-10-31	Depomed Inc	Formas de dosagem oral de farmacos com retencao gastrica para a libertacao controlada de farmacos altamente soluveis
CA2320900C (en) *	1998-03-19	2009-10-27	Bristol-Myers Squibb Company	Biphasic controlled release delivery system for high solubility pharmaceuticals and method
US6099859A (en) *	1998-03-20	2000-08-08	Andrx Pharmaceuticals, Inc.	Controlled release oral tablet having a unitary core
US6117451A (en) *	1998-08-25	2000-09-12	Pharmalogix, Inc.	Direct compression metformin hydrochloride tablets
DE69927708T2 (de) *	1998-12-23	2006-07-06	Alza Corp., Mountain View	Dosierungsformen, die poröse partikel enthalten
DK1322158T3 (da) *	2000-10-02	2012-11-19	Usv Ltd	Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf

2002
- 2002-11-06 KR KR1020047006875A patent/KR20050043765A/ko not_active Withdrawn
- 2002-11-06 EA EA200400628A patent/EA200400628A1/ru unknown
- 2002-11-06 WO PCT/IB2002/004647 patent/WO2003039527A1/en not_active Ceased
- 2002-11-06 PL PL02369328A patent/PL369328A1/xx not_active Application Discontinuation
- 2002-11-06 EP EP02802686A patent/EP1465612A1/en not_active Withdrawn
- 2002-11-06 HU HU0402058A patent/HUP0402058A3/hu unknown
- 2002-11-06 US US10/289,070 patent/US20030104059A1/en not_active Abandoned
- 2002-11-06 CN CNA028264266A patent/CN1700910A/zh active Pending
2004
- 2004-05-12 ZA ZA200403614A patent/ZA200403614B/xx unknown

Also Published As

Publication number	Publication date
HUP0402058A3 (en)	2006-04-28
CN1700910A (zh)	2005-11-23
US20030104059A1 (en)	2003-06-05
EA200400628A1 (ru)	2004-12-30
HUP0402058A2 (hu)	2005-02-28
WO2003039527A1 (en)	2003-05-15
PL369328A1 (en)	2005-04-18
KR20050043765A (ko)	2005-05-11
EP1465612A1 (en)	2004-10-13

Publication	Publication Date	Title
HUP0402004A3 (en)	2008-08-28	Modified release tamsulosin tablets
AU2002327068A1 (en)	2003-04-14	Immediate release tablet
AU2002301845A1 (en)	2003-06-12	Modified release tamsulosin tablets
TWI347202B (en)	2011-08-21	Controlled release preparation
ZA200204020B (en)	2003-11-21	Use of anti-CTLA-4-antibodies.
MXPA03009229A (es)	2004-01-29	Microcapsulas.
MXPA03009558A (es)	2004-02-12	Compuestos novedosos.
EP1581160A4 (en)	2009-08-12	ENCAPSULATION PRODUCTS PROVIDING CONTROLLED OR PROLONGED DELIVERY
AU2002363360A1 (en)	2003-05-19	Dual controlled release dosage form
ZA200409617B (en)	2006-02-22	Microcapsule formulations.
HUP0500004A3 (en)	2012-09-28	Extended release pharmaceutical tablet of metformin
ZA200403614B (en)	2005-01-14	Controlled release tablets of metformin.
EP1372614A4 (en)	2007-10-31	SULPHONYL UREA FORMULATION WITH CONTROLLED RELEASE
IL163887A0 (en)	2005-12-18	Controlled release dosage forms
IL162019A0 (en)	2005-11-20	Mousse
EP1335708A4 (en)	2005-07-13	METFORMIN COMPOSITIONS WITH CONTROLLED RELEASE
GB0124338D0 (en)	2001-11-28	Biochips
EP1457204A4 (en)	2007-11-14	SHAPED PRODUCT OF RELEASE CONTROL TYPE
GB0115761D0 (en)	2001-08-22	Capsules
HK1070571A (en)	2005-06-24	Controlled release tablets of metformin
AU2002363392A1 (en)	2003-05-19	Controlled release tablets of metformin
GB2375521B (en)	2004-04-28	Davits
ZA200305944B (en)	2005-05-25	Novel modified release formulation.
ZA200104935B (en)	2002-12-11	Extended release buccal tablet.
AU2002343227A1 (en)	2003-05-19	Modified release tamsulosin tablets